Clinical Trial Update: A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial update for AZD1163 in rheumatoid arthritis, with the study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• AZD1163

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis | Phase 2 | Status: RECRUITING